NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Is Plug Power a Bargain After New Hydrogen Deals and a 93.8% Five Year Slump?

If you are wondering whether Plug Power at around $2 a share is a beaten-down bargain or a value trap, you are not alone. This is exactly what we are going to unpack. The stock has bounced about 11.1% over the last month, but it is still down 5.6% year to date and a huge 93.8% over five years. This suggests that sentiment has been on a long, painful slide. Recent headlines have focused on Plug Power securing new green hydrogen and fuel cell deployment deals, as well as ongoing funding and...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

How Investors May Respond To Exelon (EXC) Expanding Utility-Backed Ultrafast EV Charging Near O’Hare

Earlier this week, Exelon subsidiary ComEd provided a US$500,000 EV rebate and infrastructure support to bp pulse to energize 40 new ultrafast charging ports near Chicago’s O’Hare Airport, creating one of the largest public charging hubs in the region. This project, delivered under Illinois’ Climate and Equitable Jobs Act, highlights how regulated utilities like Exelon can earn returns while supporting state clean-energy and EV adoption goals through grid and charging investments. We’ll now...
NYSE:IP
NYSE:IPPackaging

International Paper (IP): Evaluating Valuation After a Year of Weak Share Performance and Rebounding Earnings

International Paper (IP) has quietly slipped over the past year, but the story is more nuanced than a simple downtrend. Recent share weakness contrasts with improving revenue and a sharp rebound in annual net income growth. See our latest analysis for International Paper. At around $38.24 per share, International Paper’s 90 day share price return of negative 17.16 percent and one year total shareholder return of negative 26.91 percent point to fading momentum despite that sharp earnings...
SEHK:6855
SEHK:6855Biotechs

Assessing Ascentage Pharma (SEHK:6855) Valuation After New ASH 2025 Hematology Data on Olverembatinib and Lisaftoclax

Ascentage Pharma Group International (SEHK:6855) just used the 67th ASH Annual Meeting as a showcase, rolling out fresh long term data on Olverembatinib and Lisaftoclax that further clarifies the story behind the stock. See our latest analysis for Ascentage Pharma Group International. The latest ASH data land after a bumpy stretch, with a 30 day share price return of minus 11.8 percent and a 90 day share price return of minus 25.1 percent. However, a much stronger year to date share price...
NYSE:YUM
NYSE:YUMHospitality

A Look at Yum! Brands (YUM) Valuation Following Its New Food Safety Alliance Commitment

Yum! Brands (YUM) is drawing fresh investor attention after joining the Alliance to Stop Foodborne Illness, a cross industry group focused on stronger food safety culture and tools that directly tie into brand trust. See our latest analysis for Yum! Brands. The move comes as Yum! Brands' share price has climbed to around $153.75, with a solid year to date share price return and healthy multi year total shareholder returns suggesting steady, not frantic, momentum as investors reward its growth...
NasdaqGS:CPB
NasdaqGS:CPBFood

Campbell's (CPB) Valuation Check After a 32% Share Price Slide Despite Improving Fundamentals

Campbell's (CPB) has had a rough stretch this year, with the stock sliding about 32% year to date even as revenue and net income are still inching higher, creating an interesting value setup. See our latest analysis for Campbell's. That slide reflects a market that is rethinking how much it is willing to pay for steady, slower growth, with the 1 year total shareholder return down 28.04% even as fundamentals improve. This suggests sentiment has weakened more than the underlying business. If...
NYSE:HGTY
NYSE:HGTYInsurance

Hagerty (HGTY): Valuation Check After Broad Arrow’s 97% Growth and $624 Million in Collector Car Transactions

Hagerty (HGTY) just reported that its Broad Arrow subsidiary handled over $624 million in collector car transactions in 2025, with 97% year over year growth. That sharp acceleration is getting investors’ attention. See our latest analysis for Hagerty. The strong Broad Arrow update lands while Hagerty’s share price sits at $13.13, and its year to date share price return of 32.89% signals building momentum, backed by a robust 3 year total shareholder return of 65.16%. If this kind of growth...
SWX:UBSG
SWX:UBSGCapital Markets

Is UBS Group (SWX:UBSG) Turning Job Cuts And Tech Centralization Into A Sharper Efficiency Story?

UBS Group AG recently outlined further Credit Suisse integration steps, including multi-wave job cuts through 2026 and leadership changes in operations and technology, with Group Technology set to report to incoming Group Chief Operating Officer Beatriz Martin from January 2026. By consolidating technology under the Group COO and emphasizing artificial intelligence and IT migration, UBS is signaling a push to streamline operations while completing the complex Credit Suisse integration. We’ll...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

Should Analyst Optimism Around Turbochargers And Zero-Emission Tech Require Action From Garrett Motion (GTX) Investors?

In recent days, Garrett Motion has attracted a wave of upbeat analyst coverage, including new ratings and refreshed research highlighting its leading role in turbochargers and emerging zero-emission technologies. This flurry of attention underscores how Garrett’s blend of internal combustion engine exposure and growing electrified offerings is reshaping how investors view its earnings resilience. We’ll now examine how this fresh analyst enthusiasm, especially around Garrett’s zero-emission...